• About
  • Innovators
  • Corporates
  • Case Studies
  • Content Hub
Leading Edge Only Leading Edge Only
  • Login
  • Join
About
Innovators
Corporates
Case Studies
Content Hub

Nathaniel Milton

Leeds Beckett University, Principal Lecturer

This user is yet to add a description about themselves

User Verified
Register for free to view their full profile
Get Started

Connection Limit

You’ve reached your connections limit

Resets on {{ date }}

Contact us
  • Innovations
Published
Healthcare & Pharmaceuticals

Alzheimer's Diagnostic Marker

A novel peptide hormone has been identified as a potential marker for Alzheimer's disease, Type 2 Diabetes mellitus and Creutzfeldt-Jakob disease. A UK patent has been granted.

By Nathaniel Milton

Reference Number   05003

Last Update   Dec 19, 2018

Register to view more


To view all of the Innovations and Members on LEO simply register for free.

if_strategy_194313 Created with Sketch.

Innovators can cut through the noise and get their innovation seen in a crowded marketplace.

if_skills_2144750 Created with Sketch.

Organisations can identify and connect to the most relevant innovations across Small Businesses, Members and Universities.

Register Now Login
Leading Edge Only
© 2025 Leading Edge Only LTD
  • About
  • About
  • Corporates
  • Innovators
  • Members
  • Partners
  • Help
  • Contact Us
  • Help Center / FAQs
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • Acceptable Use Policy
  • Supported Browsers
  • Functions
  • Add your Innovation
  • Create your Challenge
  • Search Innovations
  • Explore
  • Challenges
  • Collaborators
  • Innovations
  • Members
  • Universities
  • Content Hub
  • Case Studies
  • Resources
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
© 2025 Leading Edge Only LTD

Your experience on this site will be improved by allowing cookies.